2024
-
14 November 2024 Affordable generics will stay relevant amid a premiumisation trend: GSK's Bhushan Akshikar
Source : The Hindu
GSK will keep its existing portfolios while entering areas like oncology, said company officials at its centenary celebrations
-
14 November 2024 GSK Celebrates Hundred Years in India
Source : Chemical Industry Digest
British biopharmaceutical firm GlaxoSmithKline (GSK) marked a significant milestone, completing hundred years of operations in India.
-
13 November 2024 'Reinvention, resilience critical to GSK's 100-year journey in India'
Source : The Hindu Business Line
British biopharmaceutical firm GSK clocked 100 years in India, in a journey that saw the making of the antibiotic penicillin to augmentin and paediatric vaccines to the recent shingles vaccine.
-
09 October 2024 GlaxoSmithKline Pharma to enter oncology market, launch adult vax
Source : The Times of India
GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines.
-
23 September 2024 Building On 100 Years In India: The Next Big Things On GSK's Horizon
Source : SCRIP Citeline Commercial
GSK’s India chief talks to Scrip about new category creation in adult
immunization with Shingrix seeing strong uptake, Nucala and Trelegy’s
trajectory and oncology assets set for debut as the company steps into its
100th year of operation in the country.
-
18 September 2024 100 Years In India – GSK’s Secret Sauce To Not Just Stay Relevant But Thrive
Source : SCRIP Citeline Commercial
GlaxoSmithKline Pharmaceuticals' MD tells Scrip how the company has
been able to reinvent itself, contemporize brands and get supply chain
innovation right as the UK-headquartered firm marks 100 years of
operations in India.
2023
The Times of India, 30/05/2023
'Anti-shingles vax a must in preventive armour of adult vaccination'
ET Brand Equity, 29/05/2023
GlaxoSmithKline and Amitabh Bachchan join forces to raise 'Shingles' awareness
Business Standard, 24/04/2023
GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD
The Hindu BusinessLine, 24/04/2023
Shingles vaccine roll-out will boost GSK’s adult vaccine kitty
2022
The Times of India, 10/12/2022
GSK Pharma bets on growing adult vaccine market
The Economic Times, 03/09/2022
GSK's pharma brands doing well: India MD
The Times of India, 29/04/2022
From childhood to adulthood: The need for life course vaccination
The Economic Times, 26/04/2022
GSK launches once daily, single inhaler-triple therapy for COPD patients
Financial Express, 26/04/2022
GSK launches single-inhaler triple therapy in India for COPD patients
ETBrandEquity, 24/02/2022
GSK and MS Dhoni team up for 6-in-1 vaccination awareness campaign
Scrip, 28/01/2022
GSK Pharma India chief on pandemic decisions, refreshing the portfolio
2021
Economic Times HealthWorld, 25/09/2021
Severe Asthma: The Implications and Effective Management
Economic Times HealthWorld, 05/05/2021
GSK Pharma India’s Dr. Markandeywar, Dr. Sharma and Dr. Gvalani uncover asthma misconceptions
2020
The Economic Times, 15/10/2020
The pandemic fast forwarded our digital journey: Sridhar Venkatesh, Managing Director, India, GSK Pharmaceuticals
The Economic Times, 01/10/2020
There is a greater need now for quick results without any compromise on efficacy and patient safety : Sridhar Venkatesh, Managing Director, GSK India
Reuters, 20/06/2020
GSK in quest to be best, not first, in race for COVID-19 vaccine
CNBC TV 18, 10/06/2020
When can we expect a COVID-19 vaccine?
2018
Business Standard, 13/06/2018
